1-((4-Chloro-3-nitrophenyl)sulfonyl)piperidine

Catalog No.: 
ACVMWE018
CAS No.: 
53162-43-9
Molecular Formula: 
C11H13ClN2O4S
Molecular Weight: 
304.76
1-((4-Chloro-3-nitrophenyl)sulfonyl)piperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$98.00InquiryInquiry
5g95%$216.00InquiryInquiry
10g95%$336.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((4-Chloro-3-nitrophenyl)sulfonyl)piperidine
IUPAC Name1-((4-chloro-3-nitrophenyl)sulfonyl)piperidine
MDL No.MFCD01004788
Molecular FormulaC11H13ClN2O4S
Molecular Weight304.76
SMILESO=S(N1CCCCC1)(C2=CC=C(Cl)C([N+]([O-])=O)=C2)=O
InChI KeyIYPKFPRPNYXJDZ-UHFFFAOYSA-N
SynonymPiperidine, 1-[(4-chloro-3-nitrophenyl)sulfonyl]-
CAS No.53162-43-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVMWE018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVMWE018 route product structure diagram
    ACVMWE01853162-43-9
Inquiry

2. ACVMWE018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVMWE018 route product structure diagram
    ACVMWE01853162-43-9
Inquiry

3. ACVMWE018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVMWE018 route product structure diagram
    ACVMWE01853162-43-9
Inquiry

Comments (0)